DOCUSIGN, INC. (DOCU) SEC Filings, Sep 15-17, 2025

DOCUSIGN, INC. (DOCU) Form 144 notifies the SEC of an intended sale of 9,509 common shares through Morgan Stanley Smith Barney on 09/17/2025, with an aggregate market value of $790,220.72 and 201,104,117 shares outstanding reported for the class. The filer shows recent acquisitions from the issuer dated 08/10/2025 and 09/10/2025 totaling 9,509 shares (mix of restricted stock and performance shares). The filer also reported two prior sales in the past three months: 11,214 shares on 07/01/2025 for $867,036.66 and 15,143 shares on 06/18/2025 for $1,132,640.37. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Form 144 filed for DOCU (DOCU) shows proposed sale of common stock by Robert Chatwani. The filing notifies an intended sale of 13,817 shares through Morgan Stanley Smith Barney on or about 09/17/2025 with an aggregate market value of $1,148,235.53. The shares to be sold were acquired as restricted stock and performance shares on 08/10/2025 and 09/10/2025, totaling 13,817 shares. The filer reported three prior open-market sales in the past three months: 22,875 shares on 06/18/2025 for $1,710,777.77, 1,682 shares on 09/15/2025 for $135,064.60, and 983 shares on 09/11/2025 for $78,040.37. The notice includes the seller's representation about absence of undisclosed material information.

DocuSign, Inc. President and CEO Allan C. Thygesen reported vesting and settlement of restricted and performance stock units on September 15, 2025, converting 65,558 units into common stock at $0.00 per share. 33,295 shares were withheld to cover taxes. He now holds 176,246 common shares, 329,269 restricted stock units and 100,082 performance stock units.

Robert Chatwani, an officer of DocuSign, reported multiple equity transactions on 09/15/2025. The filing shows a sale of 1,682 shares at $80.30 executed pursuant to a Rule 10b5-1 plan and disposition of 16,020 shares withheld by the issuer to satisfy tax obligations upon RSU/PSU vesting. The report also records a non-priced acquisition of 31,538 shares and numerous restricted stock units and performance stock units granted or settled, increasing holdings across several award series. Post-transactions, beneficial ownership figures are shown for each line (for example, 100,999 shares following one reported acquisition). The Form 4 discloses vesting schedules and performance criteria for PSUs and RSUs but does not provide company results or broader financial guidance.

DocuSign CFO Blake Grayson reported multiple equity transactions on 09/15/2025, primarily reflecting the vesting and settlement of restricted stock units (RSUs) and performance stock units (PSUs). The filing shows 37,449 shares acquired and 15,289 shares withheld to satisfy tax obligations, leaving the reporting person with 136,958 shares after the transactions. Several RSU grants vest over multi‑year schedules (quarterly over four years or front‑loaded schedules) and PSUs vest subject to FY25 subscription revenue and free cash flow performance with a 200% maximum payout, with earned PSUs vesting partially after one year then in quarterly installments. All reported holdings are direct.

Paula Hansen, Chief Revenue Officer of DocuSign, Inc. (DOCU), reported transactions dated 09/15/2025. The filing shows an acquisition of 80,455 shares of common stock and a disposal of 40,857 shares (withholding to satisfy tax obligations), leaving 105,580 and 64,723 shares beneficially owned following those reported non-derivative transactions, respectively. The report also records awards of restricted stock units (RSUs) and performance stock units (PSUs) settled on 09/15/2025, including 63,920 RSUs, 4,033 RSUs, and PSUs of 7,324 and 5,178 units, with resulting beneficial ownership totals shown in the filing. Vesting schedules and performance conditions for these awards are described in the explanatory notes.

Anna Marrs, a Director of DocuSign, Inc. (DOCU), reported a sale of company stock under a pre-established trading plan. On 09/15/2025 she disposed of 728 shares of DocuSign common stock at a reported price of $80.3 per share. After the sale she beneficially owned 10,799 shares, held directly. The filing notes the transaction was effected pursuant to a Rule 10b5-1 plan. The Form 4 was signed by an attorney-in-fact on 09/16/2025.

DocuSign (DOCU) Form 144 notice reports a proposed sale of 15,000 shares of common stock through Merrill Lynch, with an aggregate market value of $1,202,850 and an indicated outstanding share count of 201,104,117. The securities were originally acquired in 2008–2009 as initial venture capital funding from Sigma Partners in three lots totaling 15,000 shares. No securities were reported sold in the past three months. The filer affirms no undisclosed material adverse information and includes the standard signature and legal warnings.

Form 144 filed for DOCU discloses a proposed sale of 728 shares of DocuSign common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $58,458.40. The filing lists the approximate date of sale as 09/15/2025 and reports total shares outstanding as 201,104,117. The shares were acquired as restricted stock from the issuer on 08/29/2025 (365 shares) and 09/04/2025 (363 shares), with payment recorded on those same dates. The filer attests they have no undisclosed material information and certifies the accuracy of the notice.